Search the Newsreel

Verici Dx plc (VRCI) Secures Olink Certification to Enhance Proteomics Services in Transplant Diagnostics

Dynex Capital, Inc. Declares Common Stock Dividend for the Month of August 2026, Payable on September 1, 2026

Dynex Capital, Inc. announced a cash dividend of $0.17 per share on its Common Stock for August 2026. The dividend is scheduled to be paid on September 1, 2026, to shareholders of record as of August 21, 2026. This announcement indicates the company's consistent …

CareDx (CDNA) Trades 68% Above Fair Value Following Strong Q2 And Raised Guidance

CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 7, 2026

CareDx, Inc. announced inducement grants of restricted stock units (RSUs) to 35 new employees as a material incentive for their employment. A total of 97,090 shares of common stock were awarded, with most RSUs vesting over four years and one employee's RSUs vesting 100% …

MDxHealth SA (MDXH) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for MDxHealth SA (MDXH), indicating a current earnings forecast score of 7.67, ranking 275th in its industry. Analysts have set an average price target of $7.00, with most recommending a "Buy" trend. The company's expected revenue for the …

DXP Enterprises (DXPE) Stock Looks Like A Bargain On Cash Flow But Full On Earnings

DXP Enterprises (DXPE) stock appears fairly valued based on both discounted cash flow (DCF) and earnings multiples, despite strong multi-year returns. While its DCF model suggests a small discount to intrinsic value at $205 per share, its P/E ratio of 32.0x is above the …

DXP Enterprises (DXPE) Posts Stronger Q2 Results, Is The Stock Now Too Pricey?

DXP Enterprises (DXPE) reported strong Q2 2026 results with increased sales, net income, and EPS, leading to a significant share price surge of 78.57% year-to-date. However, a popular narrative suggests the stock is 13.2% overvalued at $192.36, with a fair value estimated at $170 …

Is DXP Enterprises (DXPE) Fully Valued As Strong Q2 Earnings Lift Interest?

DXP Enterprises, Inc. $DXPE Shares Sold by Oliver Luxxe Assets LLC

Oliver Luxxe Assets LLC significantly reduced its stake in DXP Enterprises, Inc. (NASDAQ:DXPE) by 40.2% in the second quarter, selling 10,721 shares. Despite this sale, institutional investors collectively own 74.82% of the company, and analysts maintain a "Moderate Buy" rating with a $187 average …

MiMedx Group, Inc Revenue Breakdown – NASDAQ:MDXG

This article provides a revenue breakdown for MiMedx Group, Inc (NASDAQ: MDXG). Last year, the company generated $418.63 million USD in total revenue, with its Wound segment being the top performer, contributing $276.33 million USD. The United States was the greatest regional contributor to …

This Insider Has Just Sold Shares In CareDx

CareDx's Independent Chairman, Michael Goldberg, recently sold US$2.1m worth of shares, reducing his total holding by 24%. While this is the largest insider sale in the past year, the shares were sold at a price close to the current market value. Despite no insider …

DXP Enterprises (NASDAQ:DXPE) Rating Increased to Buy at Wall Street Zen

Wall Street Zen has upgraded DXP Enterprises (NASDAQ:DXPE) from a "Hold" to a "Buy" rating. The stock now holds a "Moderate Buy" consensus among analysts with a target price of $187, following impressive quarterly earnings that surpassed expectations. Shares opened at $192.36, near their …

MiMedx Group Inc (MDXG) Stock News Today

This article from TradingKey provides current stock information for MiMedx Group Inc (MDXG), including its stock price, market cap, and P/E ratio. It notes that more news regarding MDXG's earnings, analyst ratings, and key developments will be available soon. The page serves as a …

MiMedx (MDXG) Q2 2026 Earnings Call Transcript

GeneDx Holdings (WGS) Is Up 18.4% After Reaffirming 2026 Outlook And Raising Equity From Blackstone

In early August 2026, GeneDx Holdings Corp. reported second-quarter revenue of US$114.44 million with a net loss of US$17.74 million, reaffirmed its full-year 2026 revenue outlook, and announced a private placement of 81,967 Class A shares at US$61.00 each with participation from a Blackstone …

State Street (CDNA holder) discloses 2.47M CareDx shares under shared control

State Street Corporation has reported a beneficial ownership of 2,468,858 shares of CareDx, Inc. common stock, which represents 4.8% of the class, according to a Schedule 13G SEC filing. All voting and dispositive authority for these shares is shared through affiliated investment adviser entities. …

WGS CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

Faruqi & Faruqi, LLP is investigating potential claims against GeneDx Holdings Corp. (NASDAQ: WGS) and reminds investors of the August 3, 2026 deadline to seek lead plaintiff status in a federal securities class action lawsuit. The lawsuit alleges that GeneDx and its executives made …

CareDx (CDNA): Neil Gagnon and Gagnon entities report 4.4% ownership stake

Neil Gagnon and his affiliated entities, Gagnon Securities LLC and Gagnon Advisors, LLC, have reported a collective ownership stake of 4.4% in CareDx, Inc. (CDNA) common stock through a SCHEDULE 13G/A SEC filing. Neil Gagnon individually beneficially owns 2,293,464 shares (4.4%), while Gagnon Securities …

CareDx (NASDAQ: CDNA) insider Peter Maag plans 27,332-share stock sale after option exercise

CareDx, Inc. insider Peter Maag has filed to sell 27,332 shares of Common Stock, which are tied to a stock option exercise dated August 7, 2026. The sale will be executed on NASDAQ through Morgan Stanley Smith Barney LLC’s Executive Financial Services program. The …

DXC Technology (DXC) Unifies AI Leadership, Is The Stock Cheap?

DXC Technology (DXC) is garnering attention following its appointment of Lisa Beaudoin as Chief Product Officer, signaling a strategic shift towards AI-focused leadership and product development. Despite a recent 0.91% share price gain, the stock is down 21.02% year-to-date and 73.04% over five years. …

CareDx Inc (CDNA) Stock News Today

Statutory Earnings May Not Be The Best Way To Understand CareDx's (NASDAQ:CDNA) True Position

CareDx's recent strong earnings report, while positive on the surface, may not fully reflect the company's underlying financial health. The analysis highlights a high accrual ratio of 0.28, indicating that free cash flow significantly lagged statutory profit, partly due to a US$109m boost from …

DXC Technology (NYSE: DXC) grants 21,800 RSUs to board director

DXC Technology (NYSE: DXC) board director Carrie W. Teffner was granted 21,800 restricted stock units (RSUs) on August 4, 2026, as reported in a Form 4 filing. Each RSU converts to one share of common stock and vests on the earlier of one year …

DXP Enterprises, Inc. (NASDAQ:DXPE) Receives Consensus Recommendation of "Moderate Buy" from Analysts

DXP Enterprises (NASDAQ:DXPE) has received a "Moderate Buy" consensus rating from five analysts, with three recommending a buy and two a hold. Despite an average 12-month price target of $154, which is below its current share price of $198.21, the company recently surpassed quarterly …

Janus Henderson Group PLC Has $5.50 Million Stock Position in CareDx, Inc. $CDNA

Janus Henderson Group PLC has increased its stake in CareDx, Inc. (NASDAQ:CDNA) by 10.1% to 316,519 shares, valued at approximately $5.5 million. This comes as CareDx reported stronger-than-expected quarterly earnings with $0.37 EPS and revenue of $131.95 million, a 52.2% year-over-year increase. Despite a …

CareDx (NASDAQ:CDNA) Is Posting Healthy Earnings, But It Is Not All Good News

CareDx, Inc. (CDNA) Stock Analysis: Strong Revenue Growth and Investor Optimism Signal Potential Upside

DXP Enterprises Inc (DXPE) Stock News Today

This article provides recent news for DXP Enterprises Inc (DXPE), highlighting its Q2 2026 earnings report. The report indicates that pumping solutions were a key driver, leading to a 15.6% increase in sales. Investors can follow the latest stock news, earnings, and analyst ratings …

DXP Enterprises Inc (DXPE) (Q2 2026) Earnings Call Highlights: Record Sales and EBITDA Fueled ...

DXP Enterprises Inc (DXPE) reported record sales and EBITDA for Q2 2026, driven by strong organic growth and successful acquisition integrations across all segments. While the company faces supply chain challenges, inflationary pressures, and a tight labor market, management expressed a cautiously optimistic outlook, …

CareDx, Inc. (CDNA) insider sells 2,688 shares under trading plan

CareDx, Inc. Secretary and General Counsel Jeffrey Adam Novack sold 2,688 shares of common stock on August 5, 2026, under a Rule 10b5-1 trading plan established in September 2025. The sales were executed in two tranches at weighted average prices of $46.1492 and $46.75 …

DXC Technology Company Just Reported A Surprise Profit, And Analysts Lifted Their Estimates

DXC Technology Company recently reported a surprise statutory profit of US$0.73 per share, exceeding analyst expectations which had predicted losses. Following these results, analysts maintained their revenue estimates of US$12.2 billion for 2027 but significantly increased their earnings per share forecast to US$1.58, indicating …

Dimensional Fund Advisors LP Has $25.38 Million Stock Position in CareDx, Inc. $CDNA

Dimensional Fund Advisors LP significantly increased its stake in CareDx, Inc. by 11.6% in the first quarter, now holding 1.46 million shares valued at $25.38 million. This comes as CareDx reported stronger-than-expected quarterly earnings and revenue. Despite mixed analyst ratings and recent insider stock …

DXP Enterprises (DXPE) Stock Jumps As Margin Strength Reshapes The Debate

DXP Enterprises (DXPE) saw its stock jump 18% after reporting strong Q2 results, including a 15.6% revenue increase, 21.6% net income rise, and a record 12.2% adjusted EBITDA margin. The market's reaction suggests a re-evaluation of the company's future profitability and its acquisition strategy. …

DXC Technology (NYSE: DXC) grants director 30,900 RSUs in stock award

DXC Technology director David L. Herzog was granted 30,900 restricted stock units (RSUs) on August 4, 2026, as reported in a recent Form 4 filing. These RSUs entitle him to one share of common stock each and will vest on the earlier of one …

DXC Technology (NYSE: DXC) grants director 21,800 restricted stock units

DXC Technology (NYSE: DXC) director Akihiko Washington was granted 21,800 restricted stock units (RSUs) on August 4, 2026. These RSUs will vest on the earlier of one year from the grant date or the 2027 annual meeting of stockholders. Following this award, Washington directly …

CareDx, Inc. (CDNA) director sells 16,000 shares in planned trade

CareDx, Inc. director Christine Cournoyer sold 16,000 shares of common stock on August 4, 2026, under a Rule 10b5-1 trading plan. The shares were sold at a weighted average price of $46.9358 per share, ranging from $46.25 to $47.2250, leaving her with 42,943 shares. …